About

Technology can help respond to the current waiting list crisis in the NHS. For example, use of Robotic-Assisted Surgery seems to demonstrate significant advantages in areas including patient satisfaction, clinical outcomes and productivity. The personalisation of surgical interventions using robotic technology will be further enhanced by AI and machine learning, with increasing connectivity to transfer and receive clinical data. The healthcare sector is benefiting already from such technologies. How can the NHS mobilise to take advantage of these successes?

J&J unites science and technology to bring life-saving medical technologies, medicines, and care to people around the globe. By combining data, artificial intelligence (AI) and machine learning (ML), and advanced computing with our scientific expertise, we are setting a new pace for discovering lifechanging treatments for patients in need. 

• How to realise tangible benefits of introducing digital technology and Robotic-Assisted Surgery in hospitals?
• Where can IT help remove roadblocks to the wide scale adoption of such techniques in areas such as core infrastructure, data management and AI?
• What role do suppliers hold in working with hospitals in ensuring seamless connectivity to digital solutions while meeting rigorous privacy requirements?
• How can the CIO assist in broader stakeholder engagement around technology adoption?

About Johnson & Johnson MedTech:

At Johnson & Johnson MedTech, we are working to solve the world’s most pressing healthcare challenges through innovations at the intersection of biology and technology. With deep expertise in surgery, orthopaedics, vision, and interventional solutions, we design healthcare solutions that are smarter, less invasive, and more personalised.